series-c-plus
Stage
1
Investors
About
Immunovant, Inc. is a clinical-stage biopharmaceutical company developing therapeutic candidates aimed at treating autoimmune diseases to help patients lead normal lives.
Explore Immunovant's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.